COVID-19 associated with concomitant mucormycosis and aspergillosis.

Lai, Chih-Cheng; Wu, Chi-Jung; Lee, Yi-Chien; Liu, Wei-Lun

Lai, Chih-Cheng; Wu, Chi-Jung; Lee, Yi-Chien; Liu, Wei-Lun.

Lai CC; Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan City, Taiwan.
Wu CJ; National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan City, Taiwan; Division of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Lee YC; Department of Internal Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan; School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Liu WL; School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; Division of Critical Care Medicine, Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan. Electronic address: medrpete

J Microbiol Immunol Infect ; 55(2): 353-354, 2022 04.

Article in English | MEDLINE | ID: covidwho-1415579

Subject(s)

Aspergillosis; COVID-19; Mucormycosis; Aspergillosis/complications; COVID-19/complications; Humans; Mucormycosis/complications; Mucormycosis/diagnosis; Mucormycosis/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspergillosis / COVID-19 / Mucormycosis Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: J Microbiol Immunol Infect Journal subject: Allergy and Immunology / Microbiology Year: 2022 Document Type: Article Affiliation country: J.jmii.2021.09.001

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google